Brii Biosciences Limited
BRIBF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $2 | $1 | $1 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$1 | -$1 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -96.4% | -37.3% | 36.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -17,435% | -673.6% | -962.7% | -1,696.2% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -14,911.1% | -819.4% | -1,266.2% | 93% |
| EPS Diluted | -0.1 | -0.16 | -0.38 | 0.021 |
| % Growth | 37.5% | 57.9% | -1,926.9% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |